Time Up and go in Hemiplegic Patients

Difficulty Walking Clinical Trial

— TUG  

Official title:

Quantification of Biomechanical Parameters of Functional Task Time Up and Go in Hemiplegic Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01807273
• Other study ID #: 2012-A01619-3
• Status: Completed
• Phase: N/A
• First received: March 7, 2013
• Last updated: February 3, 2015
• Start date: March 2013
• Est. completion date: November 2014

Study information

• Verified date: January 2014
• Source: Centre d'Investigation Clinique et Technologique 805
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
• Study type: Observational

Clinical Trial Summary

Investing the Timed Up and Go (TUG) Test in Hemiplegic Patients Using 3D Motion Analysis

Description:

The timed up and go is a routine quick test assessing motor functional tasks including stand up ,walk 3 m,turn around and sitting down.We will included hemiplegic patients to quantify biomechanic parameters

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: November 2014
• Est. primary completion date: March 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients performing 3D gait analysis

• Male or female adults aged = 18 years,

• Hemiplegia following unique stroke- Patients with hemiplegia able to stand up alone,walk and turn around alone without assistance.

Exclusion Criteria:

• Patient with a protective measure,

• Pregnant women, breastfeeding

• Brain damage bilateral cerebellar syndrome, apraxia and / or severe aphasia,

• Patient who received botulinum toxin injection in the 3 months prior to inclusion, patients who underwent surgery of the locomotor system in the 6 months prior to inclusion,

• No affiliation to a social security

• other pathology, complications with significant impact on the activities of walking.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Difficulty Walking

Intervention

Other:
• Walking test

Locations

Country	Name	City	State
France	Hopital Raymond Poincare	Garches

Sponsors (1)

Lead Sponsor	Collaborator
Centre d'Investigation Clinique et Technologique 805

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Variability of the center of mass	subjects will perform the TUG test with 3D walk analysis equipment	1 hour	No